174 related articles for article (PubMed ID: 37597363)
21. Evaluation of Indolocarbazoles from
Rizo-Liendo A; Sifaoui I; Cartuche L; Arberas-Jiménez I; Reyes-Batlle M; Fernández JJ; Piñero JE; Díaz-Marrero AR; Lorenzo-Morales J
Microorganisms; 2020 May; 8(5):. PubMed ID: 32466301
[No Abstract] [Full Text] [Related]
22. Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri.
Arberas-Jiménez I; Rizo-Liendo A; Nocchi N; Sifaoui I; Chao-Pellicer J; Souto ML; Suárez-Gómez B; Díaz-Marrero AR; Fernández JJ; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2022 Mar; 147():112694. PubMed ID: 35131659
[TBL] [Abstract][Full Text] [Related]
23. Genotyping and Molecular Identification of Acanthamoeba Genotype T4 and Naegleria fowleri from Cerebrospinal Fluid Samples of Patients in Turkey: Is it the Pathogens of Unknown Causes of Death?
Aykur M; Dirim Erdogan D; Selvi Gunel N; Guler A; Biray Avci C; Celebisoy N; Gunduz C; Dagci H
Acta Parasitol; 2022 Sep; 67(3):1372-1383. PubMed ID: 35864411
[TBL] [Abstract][Full Text] [Related]
24. The type 2 statins, cerivastatin, rosuvastatin and pitavastatin eliminate Naegleria fowleri at low concentrations and by induction of programmed cell death (PCD).
Rizo-Liendo A; Arberas-Jiménez I; Sifaoui I; Reyes-Batlle M; Piñero JE; Lorenzo-Morales J
Bioorg Chem; 2021 May; 110():104784. PubMed ID: 33684715
[TBL] [Abstract][Full Text] [Related]
25. Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri.
Baig AM
ACS Chem Neurosci; 2016 Aug; 7(8):1026-9. PubMed ID: 27447543
[TBL] [Abstract][Full Text] [Related]
26. Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases.
Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Reyes-Batlle M; Chiboub O; Rodríguez-Expósito RL; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Sci Rep; 2020 Oct; 10(1):17731. PubMed ID: 33082417
[TBL] [Abstract][Full Text] [Related]
27. Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box.
Chao-Pellicer J; Arberas-Jiménez I; Sifaoui I; Piñero JE; Lorenzo-Morales J
Int J Parasitol Drugs Drug Resist; 2024 May; 25():100545. PubMed ID: 38718717
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the membrane proteins from Naegleria species: A 23-kDa protein participates in the virulence of Naegleria fowleri.
Flores-Huerta N; Sánchez-Monroy V; Rodríguez MA; Serrano-Luna J; Shibayama M
Eur J Protistol; 2020 Feb; 72():125640. PubMed ID: 31794894
[TBL] [Abstract][Full Text] [Related]
29. Primary Amoebic Meningoencephalitis: Potential Application of Ionic Liquids Against Brain-Eating Amoebae?
Siddiqui R; Abouleish MY; Khamis M; Ibrahim T; Khan NA
Acta Parasitol; 2022 Jun; 67(2):1032-1034. PubMed ID: 35294972
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle-Terpene Fusion: A Game-Changer in Combating Primary Amoebic Meningoencephalitis Caused by
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Omega; 2024 Mar; 9(10):11597-11607. PubMed ID: 38497026
[TBL] [Abstract][Full Text] [Related]
31. Primary Amoebic Meningoencephalitis by
Güémez A; García E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
[No Abstract] [Full Text] [Related]
32. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
33. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.
Sarink MJ; Tielens AGM; Verbon A; Sutak R; van Hellemond JJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513800
[TBL] [Abstract][Full Text] [Related]
35. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
36. Next generation imidazothiazole and imidazooxazole derivatives as potential drugs against brain-eating amoebae.
Akbar N; Siddiqui R; El-Gamal MI; Khan NA; Zaraei SO; Saeed BQ; Alharbi AM; Dash NR
Parasitol Res; 2024 Jun; 123(6):241. PubMed ID: 38864931
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Naegleria fowleri strains isolated from human cases of primary amoebic meningoencephalitis in Mexico.
Cervantes-Sandoval I; de Serrano-Luna JJ; Tapia-Malagón JL; Pacheco-Yépez J; Silva-Olivares A; Galindo-Gómez S; Tsutsumi V; Shibayama M
Rev Invest Clin; 2007; 59(5):342-7. PubMed ID: 18268889
[TBL] [Abstract][Full Text] [Related]
38. Naegleria fowleri: differential genetic expression following treatment with Hesperidin conjugated with silver nanoparticles using RNA-Seq.
Siddiqui R; Rajendran K; Abdella B; Ayub Q; Lim SY; Khan NA
Parasitol Res; 2020 Jul; 119(7):2351-2358. PubMed ID: 32451717
[TBL] [Abstract][Full Text] [Related]
39. Cyclolauranes as plausible chemical scaffold against Naegleria fowleri.
Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Morales EQ; Piñero JE; Lorenzo-Morales J; Díaz-Marrero AR; Fernández JJ
Biomed Pharmacother; 2022 May; 149():112816. PubMed ID: 35286966
[TBL] [Abstract][Full Text] [Related]
40. Role of cathepsin B of Naegleria fowleri during primary amebic meningoencephalitis.
Rodríguez-Mera IB; Carrasco-Yépez MM; Vásquez-Moctezuma I; Correa-Basurto J; Salinas GR; Castillo-Ramírez DA; Rosales-Cruz É; Rojas-Hernández S
Parasitol Res; 2022 Nov; 121(11):3287-3303. PubMed ID: 36125528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
